Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.
about
Advances and Challenges in Studying Hepatitis B Virus In VitroTwo Effective Routes for Removing Lineage Restriction Roadblocks: From Somatic Cells to HepatocytesFumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver diseaseNew and old technologies for organ replacement.Cellular therapy for liver diseaseA preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes.High efficient differentiation of functional hepatocytes from porcine induced pluripotent stem cells.DMSO efficiently down regulates pluripotency genes in human embryonic stem cells during definitive endoderm derivation and increases the proficiency of hepatic differentiation.Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes.Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment.Application of Induced Pluripotent Stem Cells in Liver DiseasesRecent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Mapping the Cell-Surface N-Glycoproteome of Human Hepatocytes Reveals Markers for Selecting a Homogeneous Population of iPSC-Derived Hepatocytes.Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studiesEngineering a perfusable 3D human liver platform from iPS cells.An evaluation of the latest in vitro tools for drug metabolism studies.Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.Progress in stem cell-based therapy for liver disease.Hepatocyte-like cells derived from induced pluripotent stem cells.Regenerative Medicine and the Biliary Tree.A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.The Mitochondrial-Derived Peptide Humanin Protects RPE Cells From Oxidative Stress, Senescence, and Mitochondrial Dysfunction.Mitochondrial biogenesis and neural differentiation of human iPSC is modulated by idebenone in a developmental stage-dependent manner.Effects of Co-Culture Media on Hepatic Differentiation of hiPSC with or without HUVEC Co-Culture.Differentiation of hepatocytes from pluripotent stem cells.Cell Expansion During Directed Differentiation of Stem Cells Toward the Hepatic Lineage.Modeling Inborn Errors of Hepatic Metabolism Using Induced Pluripotent Stem Cells.Stem Cell Therapies for Treatment of Liver Disease.Multiplexed Microsphere Suspension-Array Assay for Urine Mitochondrial DNA Typing by C-Stretch Length in Hypervariable Regions.Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine.Drug-induced steatohepatitisPeripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performanceNoncoding RNA Transcripts during Differentiation of Induced Pluripotent Stem Cells into HepatocytesRecapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells
P2860
Q26771134-821403A5-71D8-4FAF-9609-CBF4147DBD2FQ26784188-27CD77BB-AAE7-431D-A8AC-66CEF1E35742Q33897291-A51E9180-BD2C-442F-A022-B89F1925E377Q34330274-81C7DE11-636D-47EB-84C5-E9C6341D0F97Q34418973-19B0F24E-E815-4BCD-9EAF-715ECE37F9A1Q34503111-21081717-E72F-4D78-8ECF-3728FB4418A3Q35192045-89D1580F-9A7F-408D-82FE-1993E6856CC2Q35557287-33873CD1-352B-4C9A-A889-FA40ED3DD967Q35661071-4981C605-1CE6-4A7A-B343-BACCBF9C2F51Q35667098-251A73E7-429B-47B8-B20B-6853DAF313A4Q36523507-5D6D3378-A479-4FCF-90C8-67B0DD15AFD2Q37121662-C961B8CD-E56F-491E-B4CF-8C3F9D986F58Q37274206-72727458-E2B9-411C-9C10-70B35C9F8456Q37537497-A800B5CC-E5D2-402A-8AA0-07064BD9ADDFQ37655140-F13BC916-224B-460F-9831-125D3AAA6739Q38160881-366D3F44-5F5A-449F-8778-8B8DA0C60AC9Q38264625-48FB5AB6-6321-4836-8CF1-4ADA1B92C2CDQ38836460-7D188C52-4F46-4D22-84DB-1DD040D8DEA7Q38929094-1CAF3E2E-E782-41C1-B81D-4C9E16D5BF96Q39136966-8B984327-1504-4AF8-AEF0-903638C0EF63Q39251464-D0A726CE-18BC-4499-B087-9EB3EA16FE81Q39618689-60CC3988-2A70-4B5E-BD55-F65B8E504B55Q41039539-0B17BDBA-5A66-434E-B165-4A429165E866Q41573890-2314C58F-9245-4EE6-AAF5-1A63682190C0Q41944061-55722F42-3A90-428E-A520-EFB8FD1761FEQ47376146-6FAEB8EB-0502-4E25-BC1A-D442529426EDQ50429584-359BDB12-FF40-4C3B-8215-124A6B409E0AQ51032622-08B44051-6464-430E-865B-F1D5C08F589AQ55333620-2B9F467B-2688-477B-BA6A-3007B501A144Q55351605-AA6DA667-B12D-4D19-BE2E-9DEF4F2607FBQ56541717-0F94DC32-AEE9-4B5C-98DF-3473FCD82331Q58375352-F91AD77B-ACD8-4B21-9364-8E45CF55C887Q58766205-CDA1FF92-2577-49AB-AE8E-C23A5182D39EQ58772479-22CD4C60-E99D-4787-854E-B6305B2EC88B
P2860
Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hepatocyte-like cells differen ...... levance to cellular therapies.
@en
type
label
Hepatocyte-like cells differen ...... levance to cellular therapies.
@en
prefLabel
Hepatocyte-like cells differen ...... levance to cellular therapies.
@en
P2093
P2860
P1433
P1476
Hepatocyte-like cells differen ...... levance to cellular therapies.
@en
P2093
Bruce P Amiot
Hongling Liu
Piero Rinaldo
Scott L Nyberg
Yasuhiro Ikeda
P2860
P304
P356
10.1016/J.SCR.2012.06.004
P577
2012-06-28T00:00:00Z